Cancers

HIGHLIGHTS

• who: Druggable Nucleolin Identifies Breast and colleagues from the Department of Clinical Research, Léon Bérard Cancer Centre, rue Laennec, FranceBreast Cancer Biology Group, Translational Research Department, PSL Research University, Institut Curie have published the paper: cancers, in the Journal: (JOURNAL)
• what: The authors show that NCL expression level is an independent marker of prognosis in breast cancer.
• how: These data indicated that NCLwho mRNA small breast but expressing intermediate NCLeven levels for compared example. These data indicated that NCL mRNA expression level is an independent marker of prognosis even when compared . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.